Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Carmine Cammarosano who wrote (1296)	8/29/1999 4:28:00 PM
From: MGV	Read Replies (1) \| Respond to of 1754

Reference in this week's Barron's interview with hedge fund manager. interactive.wsj.com Q: Which themes have driven your performance? A: One is laser surgery to correct myopia. Our holdings in this group are VISX, a maker of lasers, and two facilities where procedures are done, the Laser Center and Laser Vision Centers. Each eye that's treated is one procedure. From 100,000 in 1996, the number of operations rose to 450,000 last year and is expected to hit 900,000 in 1999. We foresee 40%-50% growth next year, to 1.3-1.4 million. Even that number is a very small percentage of the potential market for this operation. Q: This group recently was clobbered. Are you still in it? A: Yes. We were long-term in them in mid-May. On a technical basis, which I'll come to later, the stocks then were substantially overbought. Rather than sell out, we hedged our positions by selling call options against them and going short against the box. Q: Why didn't you just sell the stocks? A: We could have, but our philosophy is to hold for long periods of time. We don't want to realize capital gains unless we absolutely have to. Q: Have you gone net long again? A: Yes. Very recently, the stocks came under enormous pressure on concerns that apparent price competition would spread nationwide. We believe the price cuts are localized and temporary, so we took off our hedges. The going price for this surgery is expensive, roughly $2,200-$2,500 per eye, and this expense is strictly out-ofpocket. It isn't reimbursable. Many people have been surprised that the price per procedure has stayed as firm as it has over the years. When we first looked at laser eye surgery back in 1992, when it was in clinical trials, patients were paying the same as they do today.

To: Carmine Cammarosano who wrote (1296)	10/4/1999 5:04:00 PM
From: Jim Mac	Respond to of 1754

The LVC market will top out far below its potential if an incisional procedure like LASIK continues to be pushed. There is a huge number of LVC candidates who will refuse to do LASIK, but will be willing to do a no-touch PRK. The LASIK push is short-sighted, no pun intended.

To: Carmine Cammarosano who wrote (1296)	10/4/1999 5:20:00 PM
From: Jim Mac	Read Replies (1) \| Respond to of 1754

Sure, but LASIK requires surgical skill, while PRK does not, while each provides the same outcome. My PRK's temporary discomfort lasted only for the first day or two, and my contacts were removed by day 3. I didn't even NEED steroid eyedrops, though I took a modest amount for the first 2-3 months. I've read the data on outcomes and steroid regimens. No one I know is willing to do LASIK, simply because of the flap cutting. All they want is a zap. You watch, now that transepithelial ablation ("no-touch") PRK is approved for marketing in U.S., those who can do it will start taking market share away from LASIK docs. I believe it's done in Honolulu Hawaii, and I won't be surprised if it spreads. Apparently, LASIK is losing favor in Europe in favor of modern PRK methods. The LVC market will top out far below its potential if LASIK is pushed to the exclusion of modern PRK methods.